Navigation

Investiment.io
Financial analysis platform

Bristol-Myers Squibb Company

BMY โ€ข NYSE

$63.33
โ–ผ0.10 (0.16%)โ€ข REGULAR

Bristol-Myers Squibb Company

$63.33
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ“Š

Key Metrics & ValuationBMY

Cash Flow Summary

Key cash flow metrics and liquidity indicators for BMY

๐Ÿ“Š
P/E Ratio
18.38
(Price-to-Earnings)
๐Ÿ“ˆ
ROE
38.2%
(Return on Equity)
๐Ÿ’ง
Current Ratio
1.26
(Liquidity)
โš–๏ธ
Debt-to-Equity
2.44
(Leverage)
๐Ÿ’ฐ
Dividend Yield
4.0%
(Annual Yield)
๐Ÿข
Market Cap
$129,656,364
(in thousands)

Key Metrics Analysis

Analyze key financial ratios and valuation metrics over time

Period:annual

Select Metrics to Compare (4 selected)

P/E Ratio Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025-22.00-11.000.0011.0022.00-300%-150%0%+150%+300%
  • P/E Ratio
  • P/E Ratio YoY Growth

Return on Equity (ROE) Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-0.00K$-0.00K$0.00K$0.00K$0.00K-400%-200%0%+200%+400%
  • Return on Equity (ROE)
  • Return on Equity (ROE) YoY Growth

Current Ratio Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.000.400.801.201.60-20%-10%0%+10%+20%
  • Current Ratio
  • Current Ratio YoY Growth

Debt-to-Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.000.801.602.403.20-45%0%+45%+90%+135%
  • Debt-to-Equity
  • Debt-to-Equity YoY Growth